APA (7th ed.) Citation

RS, P., ZA, R., V, G., R, C., B, S., DK, M., . . . D, S. (2026). First-in-human clinical trial of high-dose sodium copper chlorophyllin: Pharmacology and efficacy as a dual immunomodulatory/antiviral agent. Phytomedicine : international journal of phytotherapy and phytopharmacology, 150, 157689. https://doi.org/10.1016/j.phymed.2025.157689

Chicago Style (17th ed.) Citation

RS, Patwardhan, et al. "First-in-human Clinical Trial of High-dose Sodium Copper Chlorophyllin: Pharmacology and Efficacy as a Dual Immunomodulatory/antiviral Agent." Phytomedicine : International Journal of Phytotherapy and Phytopharmacology 150 (2026): 157689. https://doi.org/10.1016/j.phymed.2025.157689.

MLA (9th ed.) Citation

RS, Patwardhan, et al. "First-in-human Clinical Trial of High-dose Sodium Copper Chlorophyllin: Pharmacology and Efficacy as a Dual Immunomodulatory/antiviral Agent." Phytomedicine : International Journal of Phytotherapy and Phytopharmacology, vol. 150, 2026, p. 157689, https://doi.org/10.1016/j.phymed.2025.157689.